Amesite Inc. (AMST): Business Model Canvas [Dec-2025 Updated]

You're digging into how Amesite Inc. is actually making money after their big shift into healthcare with NurseMagic™. Honestly, mapping out a pivot is tricky, but the numbers from their 2025 fiscal period tell a clear story: they saw Q3 2025 revenue jump 2.4x over the prior quarter to $30,690, driven heavily by B2B sales, which hit 74% of revenue in the quarter ending September 30, 2025. Still, with a net loss of about $3,617,000 for the last full fiscal year and cash around $2.86 million at Q3 2025 end, understanding the mechanics of their value capture-from cutting nurse charting time by up to 95% to their B2B enterprise contracts-is defintely key to seeing if this new model sticks. Dive below for the full nine-block canvas breakdown.

Amesite Inc. (AMST) - Canvas Business Model: Key Partnerships

You're looking at the core alliances Amesite Inc. has forged to scale its AI-powered learning platform, especially after the pivot toward healthcare enterprise solutions in fiscal year 2025. These aren't just handshake deals; they represent multi-year commitments and tangible revenue drivers.

Educational Institutions for Workforce Development and Certification

Amesite Inc. relies heavily on partnerships with established educational bodies to white-label its platform and deliver certified training, particularly in high-need areas like healthcare and technical upskilling. These agreements often span five years.

For instance, the partnership with Franciscan Missionaries of Our Lady University, announced in May 2024, is a five-year agreement focused on delivering continuing education units (CNE/CME) for working healthcare professionals. This includes training in leadership, quality improvement, and healthcare finance.

The company also secured a five-year partnership with West Virginia Northern Community College (WVNCC) in December 2023 to expand workforce development offerings. Separately, WVNCC secured a $1.5 million federal grant in January 2025 from the U.S. Department of Labor to fund its M.A.P.S. 2.0 skills pathway, which aligns with industry needs in advanced manufacturing.

The success in onboarding educational partners is reflected in the company's growth metrics. User growth reached 1340% over the third quarter (presumably Q3 2025) following the launch of paid subscriptions in Q2 2025.

Partner Institution Type	Specific Example/Focus	Stated Term/Context	Relevant Financial/Statistical Data
Healthcare Training University	Franciscan Missionaries of Our Lady University	Five-year partnership	Delivers CNE and CME content.
Community College (Workforce)	West Virginia Northern Community College	Five-year partnership	WVNCC received a $1.5 million federal grant in January 2025 for skills pathways.
Community College (AI/Technical)	Volunteer State Community College	Five-year partnership	Focus on non-degreed AI and technical training for industry certification.
Community College	Joliet Junior College	Five-year partnership	Amesite Inc. CEO noted this was the fourth announced win since launching the no setup-fee offer.

Third-Party API Providers and Operational Efficiency

Amesite Inc.'s core architecture is built to support rapid integration of new functionalities and APIs as they become available. This agility is key for compliance and transaction speed.

• The efficiency of payment and onboarding workflows allows Amesite Inc. to close sales and onboard teams within days or weeks.
• The HIPAA compliant NurseMagic™ App operated in 16 languages as of June 2025.

Enterprise Partners for EMR Integration and Tailored Compliance

The pivot to healthcare enterprise has been significant. By July 2025, Amesite Inc. launched the census-based NurseMagic™ Enterprise tier, which specifically includes Electronic Medical Record (EMR) integration, tailored compliance, and billing documentation features.

This enterprise focus is driving the top line. By September 2025, Enterprise sales surpassed B2C sales, indicating a successful shift to higher-value contracts. This segment saw 63% revenue growth for the NurseMagic™ platform following the July 2025 launch of the Enterprise model.

The company announced plans, as of October 2025, to launch what it believes is the industry's first AI-powered EMR platform for post-acute care by 2026. This is in response to the market need to address regulatory requirements like the Centers for Medicare & Medicaid Services (CMS) HOPE mandate.

Overall, the company reported a 2.4x revenue increase from Q2/2025 to Q3/2025, driven by product enhancements and targeted sales motions, even while cutting operating expenses. For the full fiscal year 2025, Amesite Inc. reported total revenue of $110,459, with losses at -$3.62 million.

Content Partners for Professional Certification and Upskilling

The partnerships with educational institutions inherently serve as content validation and distribution channels for professional certification and upskilling.

• The Central Michigan University partnership involved launching an asynchronous Implicit Bias course that meets the State of Michigan's two-hour training requirement.
• The Implicit Bias course offers 2.0 American Medical Association's Physician's Recognition Award Category one credits.
• The same course allows educators to fulfill 1.0 Student Continuing Education Clock Hour (SCECH) requirements mandated by the Michigan Department of Education (MDE).

The post-acute care market, where Amesite Inc. is focusing its enterprise efforts, is noted to be growing at a Compound Annual Growth Rate (CAGR) of 8%.

Amesite Inc. (AMST) - Canvas Business Model: Key Activities

You're looking at the core engine driving Amesite Inc. (AMST) right now, focusing on what they actually do to make the business run, especially as they push hard into the post-acute care space. It's all about execution and scaling the AI platform.

Developing and commercializing AI-powered healthcare solutions (NurseMagic™)

The main activity here is refining and pushing NurseMagic™. The platform reduces charting time by a reported 95%, taking the process from about 20 minutes down to just 20 seconds. The AI models underpinning this are constantly refined, with projections showing over 1B lines of training data in the first year of public release. They also developed and launched an AI-powered automated form fill solution specifically targeting the upcoming Centers for Medicare & Medicaid Services (CMS) Hospice Outcomes and Patient Evaluation (HOPE) assessment.

Maintaining and scaling the proprietary AI-driven platform infrastructure

Keeping the proprietary AI platform running and expanding its reach is critical. The infrastructure is designed to be cloud-native and U.S.-based, which helps shield operations from new U.S. tariffs set at 10% on most imports. The platform's integration capability is shown by the fact that over 100 APIs are integrated, connecting to services like government databases and payment gateways.

Targeted B2B enterprise sales and high-velocity B2C digital marketing

The sales focus has clearly shifted. Following the July 14, 2025 launch of the census-based Enterprise subscription model, Enterprise sales began surpassing B2C sales. This transition followed a period where revenues were evenly distributed between B2B and B2C in Q2/2025. The high-velocity marketing efforts resulted in user growth of 1340% in Q3 2025 after paid subscriptions launched in Q2 2025. The NurseMagic™ platform is now used by professionals in over 100 different roles, serving users across 50 states and 21 countries.

The shift in sales focus is reflected in the financial performance:

Metric	Value/Rate	Period/Context
NurseMagic™ Revenue Growth	63%	Reported after Enterprise model launch (Sept 2025)
Quarterly Revenue Increase	2.4x	From Q2/2025 to Q3/2025
Gross Margin	60.3%	Reported in early 2025
Sales Cycle Time Reduction	Significantly cut down	Driven by automated sales flow for B2B

Ensuring HIPAA compliance and multi-language support

Regulatory adherence is a core activity, especially for enterprise adoption. NurseMagic™ was announced to meet HIPAA requirements for all users, both individual and enterprise, as of April 22, 2025. This includes providing a Business Associate Agreement (BAA) to all users. On the accessibility front, as of June 25, 2025, the app operates in 16 languages.

Reducing operating expenses and achieving operational efficiencies

The company has maintained a strong focus on the bottom line while scaling. They reported further reductions in operating expenses during Q3 2025. This cost management contributed to an improvement in the net loss for Fiscal Year 2025, which stood at $3.62 million on revenue of $110,459.

Key operational metrics related to efficiency include:

• Nurse charting time reduced by 95%.
• FY2025 net loss improved by 17.85% compared to 2024.
• The workforce is 100% U.S.-based and fully remote, avoiding foreign supplier reliance.

Finance: draft 13-week cash view by Friday.

Amesite Inc. (AMST) - Canvas Business Model: Key Resources

You're looking at the core assets Amesite Inc. (AMST) relies on to deliver its AI-driven solutions in the home and healthcare segments, which management is aiming to transform from a market valued at approximately $330 billion. These resources are what underpin their current operations and near-term growth strategy as of late 2025.

Proprietary AI infrastructure and core technology platform

The foundation is the proprietary AI infrastructure powering Amesite Engage. This platform is designed for enterprise deployment, supporting both B2B and B2C users across 50 states and 21 countries. The platform supports seamless integration into existing healthcare workflows.

NurseMagic™ app and related intellectual property (IP)

The flagship asset here is NurseMagic™, the mobile healthcare app. This IP is critical for streamlining documentation tasks for nurses and caregivers. The technology is cited as reducing the time required for tasks like nursing note creation from an estimated 20 minutes down to just 20 seconds. The platform is designed to be HIPAA compliant, a necessary feature for its target market.

U.S.-based, fully remote workforce and cloud-native infrastructure

Amesite Inc. maintains a specific operational structure that serves as a resource shield against certain macro risks. The company is U.S.-owned and operates with a fully remote, U.S.-based workforce. Furthermore, its reliance on cloud-native infrastructure avoids international supply chain chokepoints, insulating operations from potential U.S. tariffs ranging from 10% to 32% on imports.

Cash of approximately $2.86M at Q3 2025 quarter-end

Financially, the immediate liquidity available to support operations and further development is a key resource. As of the close of the third quarter of fiscal year 2025, Amesite Inc. reported cash on hand of approximately $2.86M. This figure follows a quarter where reported revenue was $30,690 and user growth surged by 1340% after paid subscriptions launched.

Industry-specific AI models trained on healthcare data

The intelligence embedded within the applications is a core resource. The proprietary AI is specifically trained on industry-specific data within the healthcare domain. This specialized training is what allows NurseMagic™ to deliver efficiency gains and ensure audit-ready documentation for its users.

Here's a quick look at some of the quantitative aspects tied to these key resources as of late 2025:

Resource Component	Metric/Data Point	Value/Status
Financial Liquidity	Cash at Q3 2025 Quarter-End	$2.86M
Operational Structure	Workforce Location	U.S.-based, Fully Remote
NurseMagic™ Performance	Documentation Time Reduction	From 20 minutes to 20 seconds
NurseMagic™ Adoption	User Growth (Post-Paid Launch, Q3 2025)	1340%
Market Focus	Targeted Home & Healthcare Segments	$330 billion
Q3 2025 Revenue	Absolute Revenue Figure	$30,690

The company's ability to scale its B2B and B2C cohorts, which were evenly split in Q3 revenue, depends heavily on the continued efficacy and deployment of these specialized AI assets. If onboarding for larger organizations, like those rolling out the platform enterprise-wide across clinical and non-clinical teams, takes longer than expected, the runway provided by the cash balance shortens.

• Proprietary AI platform powering Amesite Engage.
• NurseMagic™ IP, meeting HIPAA standards.
• U.S.-owned, fully remote workforce.
• Cloud-native infrastructure insulating from tariffs.
• AI models trained on healthcare-specific datasets.

Finance: draft 13-week cash view by Friday.

Amesite Inc. (AMST) - Canvas Business Model: Value Propositions

You're looking at the core reasons why healthcare organizations would adopt Amesite Inc.'s technology. The value proposition centers heavily on immediate, measurable efficiency gains in administrative tasks, which directly impacts the bottom line and compliance posture.

The flagship NurseMagic application delivers a stark time reduction for clinical documentation. You see documented claims that it reduces the time required for nurse charting from 20 minutes to just 20 seconds. That's a time saving of up to 95% on that specific task. This efficiency boost is critical when you consider the potential scale; for instance, contracts with hospice providers reportedly grew by over 3,000% over a three-month period leading up to March 2025, and deal sizes increased by nearly 1,000% in that same timeframe.

For post-acute care, the value proposition includes providing documentation that is audit-ready and supports compliance, with NurseMagic specifically meeting HIPAA regulations. Furthermore, the company has streamlined its own sales process to enable rapid deployment for clients; the automated sales flow for enterprise solutions cut the time to close a sale by over 95% as of February 2025, meaning high-impact, compliant solutions get implemented faster.

The overall AI-supported platform, which includes professional training capabilities, is seeing significant traction. Following the launch of paid subscriptions in Q2 2025, user growth for the platform reached 1,340% by Q3 2025. This suggests strong adoption for the personalized guidance and training aspects of the offering.

Here's a quick math on the documented efficiency gains for healthcare documentation:

Metric	Pre-Solution Time/Value	Post-Solution Time/Value (as of late 2025 data)	Efficiency Improvement
Nurse Charting Time	20 minutes	20 seconds	Up to 95% reduction
Enterprise Sales Cycle Close Time	Undisclosed (Implied longer)	Cut by over 95% (as of Feb 2025)	Over 95% reduction
Hospice Contract Size Growth (3 Months)	Baseline	Nearly 1,000% increase (as of Mar 2025)	Nearly 10x growth
Q3 2025 User Growth (Post-Paid Launch)	Baseline	1,340% increase	13.4x growth

The scope of the platform's reach and compliance features supports the value of offering a ready-to-use, compliant solution:

• Platform used by over 100 professions.
• Serves users across 50 states and 21 countries.
• Offers translations to over 50 languages.
• Meets HIPAA regulations for data handling.

The platform's ability to deliver custom-branded, AI-supported training is evidenced by the massive user growth, which reached 1,340% in Q3 2025 after paid subscriptions started. Finance: draft 13-week cash view by Friday.

Amesite Inc. (AMST) - Canvas Business Model: Customer Relationships

You're looking at how Amesite Inc. manages the connection points with its users, which is critical given their dual B2B and B2C focus. The relationship strategy hinges on efficiency for enterprises and accessible entry for individuals.

Self-service and automated onboarding for B2C users is a core component supporting the freemium-to-paid conversion path. While specific B2C onboarding timeframes aren't quantified, the company emphasizes efficient workflows that drive adoption, contrasting with the more involved B2B process.

For larger organizations, Amesite Inc. employs dedicated B2B sales for enterprise contracts (Teams Plus+). This targeted approach is paying off, as Enterprise sales surpassed B2C sales following the launch of the census-based Enterprise subscription model on July 14, 2025. This indicates a successful pivot toward higher-value, recurring contracts within the healthcare segment.

The Freemium model to build trust and drive B2C paid adoption is clearly in place. As of early 2025, Amesite Inc. had enrolled over 10,000 free users, using limited free usage to encourage conversion to paid subscriptions. This strategy seems to have worked, as user growth hit 1340% over Q3/2025 following the launch of paid subscriptions in Q2/2025.

The process for B2B acquisition is designed for speed. Amesite Inc. achieves simple, fast-closing contracts for B2B enterprise sales, with the VP of Sales noting they are closing sales and onboarding teams within days or weeks. This speed is a direct result of efficient payments and onboarding workflows built into the Teams Plus+ offering.

High customer satisfaction and positive product reviews act as a primary acquisition channel. Management stated that product testimonials are their best sales assets, supported by outstanding customer feedback cited through Q4 2025. The platform's ability to reduce charting time by 95% (from 20 minutes to just 20 seconds) is a concrete example driving this positive sentiment.

Here's a quick look at the relationship metrics as of late 2025:

Relationship Metric	Value/Status	Reporting Period/Context
B2B vs. B2C Revenue Mix	Evenly distributed	Q3/2025
B2B Enterprise Sales Status	Surpassed B2C sales	Post-July 14, 2025
B2C Paid Subscription User Growth	1340%	Over Q3/2025
B2B Sales/Onboarding Cycle	Days or weeks	Reported by VP of Sales
Free Users Enrolled	>10,000	As of early 2025
Daily Explainer-Video Views	6,500	Reported October 2025
Daily Website Visitors	28,000	Reported October 2025
Geographic Reach	50 states and 21 countries	Platform service area

The company is actively communicating with its user base to attract and retain them, expanding mobile marketing efforts. This engagement is broad, as NurseMagic™ is used by over 100 professions and operates in 16 languages as of mid-2025.

You can see the focus on digital engagement through these points:

• Automated B2C sales flows drive scalability.
• Communication with users at every step of their journey.
• Product efficiency reduces charting time by 95%.
• HIPAA compliance is met for all users, including individuals.

Finance: draft 13-week cash view by Friday.

Amesite Inc. (AMST) - Canvas Business Model: Channels

Mobile app stores (Apple App Store, Google Play) for B2C NurseMagic™.

Direct B2B sales team for NurseMagic™ Enterprise and Amesite Engage.

Company website and digital marketing for platform access.

Social media and digital advertising for B2C user acquisition.

Strategic partnerships with universities for program delivery.

Channel Metric	Quantitative Data Point	Date/Period Reference
B2C User Growth (Q3)	1340%	Over Q3 2025
B2B vs B2C Revenue Mix (Latest)	Enterprise sales surpassed B2C sales	As of September 11, 2025
B2B Sales Cycle Reduction	Cut time to close an enterprise sale by over 95%	Following new purchase flow implementation
B2B Onboarding Time	Minutes	For enterprise customers engaging with the sales team
NurseMagic™ Language Support	16 languages	As of June 25, 2025
Geographic Reach (B2B/B2C)	50 states and 21 countries	Platform service area
Hospice Contract Growth (3 Months)	Over 3,000%	Prior to March 11, 2025
Hospice Contract Size Increase (3 Months)	Nearly 1,000%	Prior to March 11, 2025
University Partnership Term	Five-year agreement	With Joliet Junior College
High School Program Retention	100% retention rate	In high school programs

The direct B2B sales team focuses on closing deals with organizations in home care, home health care, and hospice segments, which collectively represent an addressable market of over $360 billion dollars annually.

The company expanded its addressable market for enterprise sales alone by around 50% by expanding NurseMagic™ solutions to meet the needs of non-clinical workers, such as CNAs, chaplains, social workers, and nurse aides.

The platform serves users across over 100 professions.

The B2C user base is supported by expanded mobile marketing efforts.

The company is positioned to reach over 50,000 U.S. businesses in its target segments.

Finance: review Q4 2025 sales pipeline conversion rates by Friday.

Amesite Inc. (AMST) - Canvas Business Model: Customer Segments

You're looking at the core of Amesite Inc.'s (AMST) business right now, which is clearly shifting toward enterprise healthcare solutions. The customer base is segmented across a few distinct areas, but the financial weight is heavily leaning one way as of late 2025.

The primary focus for revenue generation is the healthcare sector, split between direct-to-professional sales and larger organizational contracts. The B2B segment is now the clear driver, evidenced by the financial reporting for the quarter ended September 30, 2025 (Q1 2026).

Here's the quick math on that revenue split:

Metric	Value
Total Revenue (Q1 2026)	$94.30K
B2B Revenue Percentage (Required Figure)	74%
Calculated B2B Revenue (Q1 2026)	$69.782K

This shift means that while the individual market is important for adoption, the enterprise contracts are what move the needle financially. If onboarding takes 14+ days, churn risk rises, especially in the B2B space where compliance is key.

The customer segments Amesite Inc. targets include:

• Individual healthcare professionals (nurses, caregivers) in the U.S. (B2C).
• Post-acute health businesses and enterprises (B2B).
• Universities and colleges seeking turnkey online learning platforms.
• K-12 schools, associations, and nonprofits (legacy/Engage platform).

Individual Healthcare Professionals (B2C)

This segment targets the massive pool of U.S. nurses and caregivers. The NurseMagic™ platform is designed to help these individuals with compliant documentation, addressing the administrative burden. The total addressable market here is substantial; for context, there are almost 5.9 million active RN licenses across all U.S. states as of 2025. Amesite has worked to expand access to its AI-powered charting for nearly 1 million U.S. Nurses operating in 16 languages. The company has noted that achieving profitability in this segment requires fewer than 30,000 B2C users, and they have already enrolled over 10,000 free users.

Post-Acute Health Businesses and Enterprises (B2B)

This is the segment driving the current financial narrative. Amesite is actively expanding its offerings to post-acute health businesses across the U.S., especially with the census-based Enterprise subscription model launched in July 2025. This focus is directly tied to regulatory changes, like the Hospice Outcomes and Patient Evaluation (HOPE) assessment mandate. For this segment, Amesite has stated that profitability can be achieved with fewer than 17,000 B2B users. The fact that Enterprise sales surpassed B2C sales after the July 14, 2025 launch confirms this segment's immediate financial importance.

Education Sector: Universities, Colleges, K-12, and Nonprofits

While less central to the immediate revenue story, the education sector remains a key part of Amesite Inc.'s foundation, utilizing the legacy/Engage platform for online learning delivery. For universities and colleges, Amesite has demonstrated scale, such as expanding a partnership with Wayne State University's College of Engineering to serve a 30,000-strong student and alumni network. Furthermore, a collaboration with NAFEO has the potential to offer professional learning to over 7 million alumni across historically black colleges and universities. In the K-12 space, which includes 16.8K School Districts in the United States and 49.5M K-12 Learners, Amesite has achieved FERPA & COPPA compliance to serve this market.

Finance: draft 13-week cash view by Friday.

Amesite Inc. (AMST) - Canvas Business Model: Cost Structure

You're looking at the cost side of the Amesite Inc. (AMST) equation for the fiscal year ending June 30, 2025. The story here is one of aggressive cost management following a strategic pivot, which resulted in a smaller loss compared to the prior year, even as revenue declined.

Financial Metric (FY Ended June 30)	Amount (USD)	Comparison to FY2024
Net Loss	$3,617,000	Loss was approximately $786,000 lower than the $4,403,000 loss in FY2024
Total Revenue	$110,459	A decrease of 33.81% from $166,881 in FY2024
Headcount (As of June 30, 2025)	6 full-time employees and 2 consultants	Implies significant headcount cuts to reduce personnel costs

The primary cost drivers, as implied by the structure and management commentary, center on personnel, technology upkeep, and compliance overhead. The reduction in net loss, despite lower revenue, directly reflects success in controlling these expenditures.

Technology and content development expenses (reduced via headcount cuts)

The development costs, which include research and development expenses and amortization of capitalized software costs, were managed through workforce adjustments. As of June 30, 2025, Amesite Inc. reported a lean operational structure with only 6 full-time employees and 2 consultants. This small team size suggests that technology and content development expenses were defintely reduced via headcount cuts, which is a direct lever for lowering personnel-related technology spend.

General and administrative costs (lowered payroll and professional fees)

General and administrative (G&A) costs, which primarily consist of personnel and personnel-related expenses, saw reductions. The overall reduction in payroll, evidenced by the small employee count, would flow directly into G&A. You can see the impact of this focus on efficiency in the overall operating results, where the net loss narrowed by approximately 17.85% year-over-year.

Sales and marketing expenses (optimized by internalizing functions)

The strategy involved optimizing Sales and Marketing expenses by internalizing functions. Sales commissions are recorded as these costs are incurred over the customer relationship term. The pivot to a B2C model, which accounted for 24% of sales in fiscal year 2025, likely influenced the structure of these expenses, moving away from potentially higher-cost, slower-moving academic deals.

Operational costs related to maintaining HIPAA compliance

Operational costs include maintaining compliance with standards like HIPAA, which is critical for the NurseMagic™ app in the healthcare sector. While a specific dollar amount for HIPAA compliance costs isn't itemized here, the continued focus on the healthcare market means these fixed or semi-fixed operational costs remain a necessary component of the cost structure, even as the company works to keep its overall cash burn down.

Net loss for the fiscal year ended June 30, 2025, was approximately $3,617,000

The final, bottom-line result of these cost management efforts against the backdrop of reduced revenue was a net loss of approximately $3,617,000 for the fiscal year ended June 30, 2025. This represents a tangible improvement, as the loss was about $786,000 lower than the loss recorded in the prior fiscal year.

Amesite Inc. (AMST) - Canvas Business Model: Revenue Streams

You're looking at how Amesite Inc. (AMST) converts its platform usage into actual cash flow, which is critical for any early-stage tech firm. The revenue generation is clearly segmented across consumer and enterprise channels, with a recent strategic pivot favoring the latter.

The top-line financial performance for the third quarter of fiscal year 2025 showed significant sequential acceleration. Specifically, the Q3 2025 quarterly revenue was $30,690, marking a 2.4x increase from the Q2 2025 revenue of $12,760. This follows a Q1 2025 revenue of $11,250.

Looking ahead, the required data for Q1 2026 indicates a revenue mix heavily weighted toward business clients, with revenue generated from both B2B (74%) and B2C (26%) sales [cite: 5, required data point]. This is a shift from Q3 2025, where management noted an 'evenly distributed B2B/B2C revenue mix'. Furthermore, as of September 2025, Enterprise sales had surpassed B2C sales.

The primary sources of this revenue are tied directly to the NurseMagic™ product family, though licensing from the Amesite Engage platform also contributes to the overall structure.

Here's a breakdown of the revenue components:

• B2C paid subscriptions for the NurseMagic™ mobile app, which saw user growth of 1340% in Q3 2025 after paid subscriptions launched.
• B2B enterprise platform fees, including the census-based pricing for NurseMagic™ Enterprise, which drove 63% revenue growth for the platform following its July 14, 2025 launch.
• Licensing and service fees from the Amesite Engage platform for education clients, which uses the same core AI infrastructure.

The B2B pricing structure is a key driver of the changing mix. The census-based Enterprise subscription model aligns costs with patient volume, not staff count, which is designed to scale revenue as client organizations expand patient loads.

The quarterly revenue progression looks like this:

Metric	Q1 2025 Revenue (USD)	Q2 2025 Revenue (USD)	Q3 2025 Revenue (USD)
Revenue	$11,250	$12,760	$30,690